| Recruiting | Adjuvant TACE in HCC With High-risk Recurrence Factors Hepatocellular Carcinoma, Adjuvant, Transarterial Chemoembolization | Phase 3 | 2026-02-01 |
| Not Yet Recruiting | The Workplace-Based Hypertension Management Program Hypertension | N/A | 2026-01-01 |
| Terminated | A Prospective Study of Cadonilimab in Hepatocellular Carcinoma After Radical Surgery With High Risk of Recurre Hepatocellular Carcinoma (HCC) | Phase 2 | 2025-02-16 |
| Unknown | Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for Hepatocellular Carcinoma | Phase 3 | 2024-07-01 |
| Unknown | Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Hepatocellular Carcinoma, Recurrence, Immune Checkpoint Inhibitor | Phase 3 | 2024-02-15 |
| Unknown | Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARP Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma | Phase 2 | 2023-12-10 |
| Not Yet Recruiting | Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitors | Phase 1 / Phase 2 | 2023-08-01 |
| Completed | HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC Liver Cancer | Phase 2 | 2022-11-10 |
| Completed | Hearing Impairment of Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | — | 2022-09-01 |
| Active Not Recruiting | PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma, Neoadjuvant Therapy, PD-1 Inhibitor | Phase 2 | 2022-07-15 |
| Completed | TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 2 | 2022-04-01 |
| Unknown | Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 3 | 2022-01-10 |
| Unknown | Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma Gastric Cancer, GastroEsophageal Cancer, Fruquintinib | Phase 2 | 2021-11-05 |
| Unknown | Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC Hepatocellular Carcinoma | Phase 2 / Phase 3 | 2021-06-01 |
| Completed | Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC Hepatocellular Carcinoma | Phase 3 | 2021-02-02 |
| Unknown | DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 3 | 2021-02-02 |
| Completed | Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic Resection Liver Cancer | Phase 3 | 2021-01-01 |
| Unknown | HR Versus RFA for Early Stage HCC Hepatocellular Carcinoma, Liver Cancer | Phase 3 | 2020-08-01 |
| Unknown | RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC) Hepatocellular Carcinoma | Phase 2 | 2020-01-10 |
| Unknown | Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer Advanced Liver Cancer | Phase 3 | 2019-12-01 |
| Unknown | Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 3 | 2019-12-01 |
| Unknown | Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma HepatoCellular Carcinoma | — | 2019-11-01 |
| Unknown | Adjuvant Radiotherapy Comparing TACE for Curative HCC Hepatocellular Carcinoma | Phase 3 | 2019-05-01 |
| Completed | Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyng Nasopharyngeal Carcinoma, Nasopharyngeal Cancer, Nasopharynx Cancer | Phase 2 | 2019-03-28 |
| Completed | Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma Hepatocellular Carcinoma | — | 2019-03-03 |
| Unknown | Albumin for Hepatocellular Carcinoma Hepatocellular Carcinoma, Hypoproteinemia | Phase 3 | 2019-03-01 |
| Unknown | Neoadjuvant Radiotherapy for HCC Involving Type I PVTT Hepatocellular Carcinoma | Phase 2 / Phase 3 | 2019-03-01 |
| Unknown | Adjuvant Therapies for Patients With HCC and MVI Hepatocellular Carcinoma | Phase 3 | 2019-02-01 |
| Completed | Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection Liver Cancer | N/A | 2019-01-05 |
| Recruiting | Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma Hepatocellular Carcinoma | — | 2019-01-01 |
| Unknown | Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphoteri Talaromyces in Human Immunodeficiency Virus Negative, To Compare Voriconazole and Amphotericin Sequential Itraconazole Therapy, To Dynamically Monitor the Anti-Interferon-γ Autoantibodies | N/A | 2018-12-30 |
| Unknown | EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors Nonfunctional Pancreatic Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor, Endoscopic Ultrasound | N/A | 2018-09-28 |
| Completed | Evaluation of a Psychological Capital Intervention to Alleviate Burnout and Regulate Immunity Among Oncology N Burnout, Psychological | N/A | 2018-09-01 |
| Unknown | The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients Hepatocellular Carcinoma | Phase 2 | 2018-05-01 |
| Unknown | The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Hepatocellular Carcinoma | Phase 2 | 2018-05-01 |
| Completed | The Value of Pelvic Magnetic Resonance Imaging in Detecting Bone Marrow Infiltration of Lymphoma Lymphoma | — | 2018-02-02 |
| Unknown | Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular HepatoCellular Carcinoma | N/A | 2017-11-01 |
| Withdrawn | FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Rectal Cancer | Phase 2 | 2017-08-11 |
| Unknown | Celebrex and Metformin for Postoperative Hepatocellular Carcinoma Liver Cancer | Phase 3 | 2017-06-02 |
| Unknown | Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients Carcinoma, Hepatocellular | N/A | 2016-10-01 |
| Unknown | MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma Lymphoma | N/A | 2016-02-01 |
| Unknown | Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein Thrombos HepatoCellular Carcinoma | — | 2016-01-01 |
| Unknown | Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications HepatoCellular Carcinoma | N/A | 2015-11-01 |
| Withdrawn | Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 2 / Phase 3 | 2015-10-01 |
| Withdrawn | Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Car Hepatocellular Carcinoma | Phase 2 / Phase 3 | 2015-10-01 |
| Withdrawn | Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 2 / Phase 3 | 2015-09-01 |
| Withdrawn | Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carc Hepatocellular Carcinoma | Phase 2 / Phase 3 | 2015-09-01 |
| Unknown | EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor | N/A | 2015-06-18 |
| Unknown | HR Versus RFA for HCC in Patients With PHT Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms, Glandular and Epithelial | Phase 3 | 2015-05-01 |
| Completed | Simo Decoction and Gum Chewing for Bowel Activity Hepatocellular Carcinoma | Phase 3 | 2015-03-01 |
| Unknown | Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer Stage II Breast Cancer, Stage III Breast Cancer | Phase 2 | 2014-06-01 |
| Completed | Effect of Parecoxib Sodium and Flurbiprofen Injection on Postoperative Shivering Postoperative Shivering | Phase 4 | 2014-04-01 |
| Unknown | EUS-guided Ethanol Ablation of an Insulinoma Insulinoma | N/A | 2014-03-01 |
| Completed | Simo Decoction and Acupuncture on POI in Colorectal Cancer Colorectal Cancer | Phase 3 | 2014-02-01 |
| Unknown | Study of DC-CIK to Treat NPC Nasopharyngeal Carcinoma | Phase 2 | 2013-05-01 |
| Unknown | A Study of DC-CIK to Treat Hepatocellular Carcinoma Hepatocellular Carcinoma (HCC) | Phase 2 | 2013-05-01 |
| Unknown | Study of DC-CIK to Treat Colorectal Cancer Colorectal Cancer | Phase 2 | 2013-03-01 |
| Unknown | the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophospham Acute Myeloid Leukemia | Phase 3 | 2012-08-01 |
| Completed | Effects of Antiviral Therapy on HBV Reactivation Liver Cancer | Phase 2 / Phase 3 | 2012-07-01 |
| Unknown | A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyng Nasopharyngeal Carcinoma | Phase 3 | 2011-11-01 |
| Completed | Study on the Evolution of Genes Mutation Related With Gastrointestinal Stromal Tumors Full Gene Sequences of c-KIT、PDGFRA and DOG1 Are Analyzed With the Screening-sequencing Approach, Investigate the Characteristics and Variations Associated With the Different Gene Mutations of c-KIT、PDGFRA and DOG1 in GIST Patients | — | 2011-04-01 |
| Completed | Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 2 / Phase 3 | 2008-01-01 |
| Completed | Corticosteroids in the Treatment of Tuberculous Pleurisy Tuberculous Pleurisy | N/A | 2006-07-01 |
| Unknown | Retrospective Analysis of the Epidemiological Change and Determinants of Prognosis of Talaromycosisof Human Im To Investigate the Characteristics and Prognostic Factors of T. Marneffei Infections and the Causes of Misdiagnosis, To Study the Recurrence Indicators and Establish a Therapeutic Effect Evaluation System of T. Marneffei Infections | — | 2003-01-01 |